BIOMAT Database Logo BIOMAT Database Logo

[The intestinal motility increasing effect of cholecystokinin octapeptide on the small intestine in man]. 1979

J Lonovics, and G Nárai, and V Varró

UI MeSH Term Description Entries
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012844 Sincalide An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas. CCK-8,Cholecystokinin Octapeptide,CCK-OP,Cholecystokinin Pancreozymin C-Terminal Octapeptide,H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,Kinevac,OP-CCK,SQ-19,844,SQ-19844,Syncalide,Cholecystokinin Pancreozymin C Terminal Octapeptide,SQ 19,844,SQ 19844,SQ19,844,SQ19844

Related Publications

J Lonovics, and G Nárai, and V Varró
Effect of cholecystokinin on small intestinal motility in suncus murinus.
October 2023, General and comparative endocrinology,
J Lonovics, and G Nárai, and V Varró
Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide.
June 1982, Science (New York, N.Y.),
J Lonovics, and G Nárai, and V Varró
The effects of graded doses of C-terminal octapeptide of cholecystokinin on small intestinal transit time in man.
March 1974, The American journal of digestive diseases,
J Lonovics, and G Nárai, and V Varró
Effect of cholecystokinin on small intestine.
June 1967, Acta physiologica Scandinavica,
J Lonovics, and G Nárai, and V Varró
Dose-related effects of cholecystokinin octapeptide administered during various phases of the migrating motor complex on small-intestinal motility in sheep.
December 2009, Acta veterinaria Hungarica,
J Lonovics, and G Nárai, and V Varró
Immunoreactive component resembling cholecystokinin octapeptide in intestine.
November 1977, Nature,
J Lonovics, and G Nárai, and V Varró
Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit.
January 1997, Digestive diseases and sciences,
J Lonovics, and G Nárai, and V Varró
Effect of graded doses of octapeptide of cholecystokinin on gallbladder size in man.
March 1973, Gastroenterology,
J Lonovics, and G Nárai, and V Varró
[Inhibition of small intestine absorption in man through the intestinal hormones secretin and cholecystokinin pancreozymin].
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
J Lonovics, and G Nárai, and V Varró
Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice.
February 2005, World journal of gastroenterology,
Copied contents to your clipboard!